Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Christopher Ty Williams"'
Autor:
Christopher Ty Williams
Publikováno v:
Nursing Clinics of North America. 56:1-21
The Food and Drug Administration (FDA) classifies herbal preparations as food supplements. New herbal supplements and products are not governed by the strict FDA drug approval process and there is no premarket approval required. The FDA prohibits man
Publikováno v:
Journal of Doctoral Nursing Practice. 13:17-24
BackgroundThe integration of oral health into primary care is often limited, despite its significant connection with many diseases, including diabetes mellitus (DM).ObjectiveThis project aimed to develop, implement, and evaluate an oral health educat
Autor:
Christopher Ty, Williams
Publikováno v:
The Nursing clinics of North America. 56(1)
The Food and Drug Administration (FDA) classifies herbal preparations as food supplements. New herbal supplements and products are not governed by the strict FDA drug approval process and there is no premarket approval required. The FDA prohibits man
Publikováno v:
The Journal for Nurse Practitioners. 13:241-249
Testosterone replacement therapy (TRT) is 1 treatment option for men with hypogonadism. When TRT is prescribed, effectiveness, patient compliance, cost, and potential side effects should be considered and used to develop an individualized treatment p
Publikováno v:
The Journal for Nurse Practitioners. 13:e17-e22
Evidence-based practice (EBP) competencies represent essential components of nursing education at all levels. The transition of EBP learning goals from the baccalaureate to the master of science in nursing and doctor of nursing practice levels provid
Autor:
Christopher Ty Williams
Publikováno v:
Nursing Clinics of North America. 51:1-11
In this article, the processing of investigational and new drug applications is described and the standard and expedited review processes are examined. The efforts of the US Food and Drug Administration to ensure greater agency transparency and fisca
Autor:
Christopher Ty, Williams
Publikováno v:
The Nursing clinics of North America. 51(1)
In this article, the processing of investigational and new drug applications is described and the standard and expedited review processes are examined. The efforts of the US Food and Drug Administration to ensure greater agency transparency and fisca